您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [财报]:健康元:2025年半年度报告 - 发现报告

健康元:2025年半年度报告

2025-08-23 - 财报 -
报告封面

Important Notice Ⅰ The Board of Directors (the “Board”), the Board of Supervisors and directors,supervisors and senior management of the Company hereby warrant the truthfulness,accuracy and completeness of the contents of the interim report (the “Report”), and thatthereare no false representations, misleading statements or material omissions containedin the Report, and severally and jointly accept responsibility. Ⅱ All the directors of the Company attended the Board meeting. Ⅲ The interim report of the Company is unaudited. Ⅳ Mr. Zhu Baoguo (朱保国), the person-in-charge of the Company, Mr. Qiu Qingfeng(邱庆丰), the person-in-charge of the Company's accounting work, and Ms. Guo Chenlu(郭琛璐), the person-in-charge of the accounting department (the head of the accountingdepartment),declare that they hereby warrant the truthfulness,accuracy andcompleteness of the financial statements contained in the Report. Ⅴ Profit distribution plan or plan for conversion of capital reserve to share capitalapproved by the Board during the Reporting Period Not applicable VI Risk declaration for the forward-looking statements √Applicable □N/A The Report contains forward-looking statements which involve the future plans, developmentstrategies, etc. of the Company, yet do not constitute substantive undertakings of the Company toinvestors. Investors should exercise caution prior to making investment decisions. VII Whether there is non-operating use of funds by the controlling shareholder and theirrelated parties No VIII Whether there is a violation of the prescribed decision-making procedures to provideexternal guarantees No IX Whether more than half of directors cannot warrant the truthfulness, accuracy andcompleteness of the Report disclosed by the Company No X Significant risk warnings There is no exceptionally significant risk that will have a material impact on the productionand operation of the Company during the Reporting Period. In this Report, the Company haselaborated on the risks and countermeasures that the Company may face inthe course of productionand operation, including industry policy risk, market risk, risk of safety and environmentalprotection, risk in price and supply of raw materials and R&D risk. For more information, pleaserefer to “Potential risks” section in Chapter 3 Management Discussion and Analysis. XI Others □Applicable √N/A Table of Contents Important Notice.............................................................................................................................2Financial Highlights........................................................................................................................5Chapter 1 Definitions......................................................................................................................6Chapter 2 Company Profile and Major Financial Indicators.....................................................8Chapter 3 Management Discussion and Analysis......................................................................12Chapter 4 Corporate Governance, Environmental and Social.................................................42Chapter 5 Major Events...............................................................................................................47Chapter 6 Changes in Equity and Shareholders........................................................................65Chapter 7 Information on Bonds.................................................................................................70Chapter 8 Financial statements...................................................................................................71 Financial Highlights Chapter 1 Definitions In this Report, unless the context otherwise requires, the following expressions shall have thefollowing meanings: Chapter 2 Company Profile and Major Financial Indicators I Company profile III Introduction of the Company's basic information IV Introduction of changes in information disclosure and places for inspection VCompany Stock Profile VIOther relevant information □Applicable√N/A VII Principal accounting data and financial indicators of the Company(I)Principal accounting data VIII Differences in accounting data under domestic and foreign accounting standards□Applicable√N/A IXItems and amounts of extraordinary gains and losses√Applicable□N/A For the items not listed in the “Explanatory Announcement No.1 for Public Company InformationDisclosures-Extraordinary Gains or Losses” that the company identifies as non-recurring gains and losses,especially those with significant amounts, as well as the extraordinary gain or loss items as illustrated inthe “Explanatory Announcement No.1 for Public Company Information Disclosures-Extraordinary Gainsor Losses” which has been defined as its recurring gain or loss items, the reasons for such classificationshould be explained. XCompanies with equity incentive plans or employee stock ownership plans may choos